Rubicon Genomics's competitors

Rubicon Genomics's competitors include Midatech Pharma, MOLOGEN, CSG Actuarial and HealthEquity
Add company...
Rubicon Genomics
Rubicon Genomics, Inc. engages in the development and commercialization of sample-specific nucleic acid library preparation products for use in research and clinical testing on next-generation sequencing (NGS), microarray, and q-PCR platforms.
Midatech Pharma
Midatech employs its proprietary self-assembling biocompatible nanoparticle technology to develop nanomedicines.
MOLOGEN
MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases.
CSG Actuarial
Rapidly-growing actuarial firm helping agents, agencies, and companies compete for Medicare Supplement, Medicare Advantage, and Final Expense Life business.
HealthEquity
HealthEquity provides a range of solutions for managing healthcare accounts.
Founding Date
Founding Date
2000
Founding Date
2000
Founding Date
1998
Founding Date
2007
Founding Date
2002
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Ann Arbor, US HQ
Locations
Milton, GB HQ
Locations
Berlin, DE HQ
Locations
Omaha, US HQ
Locations
Draper, US HQ
Overland Park, US
Tucson, US
Employees
Employees
7 13% decrease
Employees
74
Employees
52 15% decrease
Employees
23
Employees
875
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
115.1 m
Valuation ($)
N/A
Valuation ($)
3.4 b
Facebook followers
Facebook followers
112
Facebook followers
47
Facebook followers
93
Facebook followers
69
Facebook followers
1.3 k
Twitter followers
Twitter followers
188
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
349
Twitter followers
873

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
£6.9m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$178.4m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
£667k (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$72m (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
£6.3m (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Gross profit
$106.4m (FY, 2017)
Net income
Net income
N/A
Net income
(£20.2m) (FY, 2016)
Net income
N/A
Net income
N/A
Net income
$26.4m (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles